Hindustan Unilever Limited (HINDUNILVR.BO)
INR 2339.0
(-0.78%)
INR 2339.0
(-0.78%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 152.56 Billion INR | -0.08% |
| 2022 | 145.71 Billion INR | 12.27% |
| 2021 | 130.47 Billion INR | 8.63% |
| 2020 | 117.68 Billion INR | 16.22% |
| 2019 | 102.58 Billion INR | 11.79% |
| 2018 | 91.73 Billion INR | 19.34% |
| 2017 | 78.24 Billion INR | 17.34% |
| 2016 | 69.25 Billion INR | 5.47% |
| 2015 | 63.95 Billion INR | 10.05% |
| 2014 | 66.42 Billion INR | 11.95% |
| 2013 | 50.89 Billion INR | 11.66% |
| 2012 | 53.17 Billion INR | 21.24% |
| 2011 | 38.56 Billion INR | 26.74% |
| 2010 | 29.66 Billion INR | 2.02% |
| 2009 | 29.07 Billion INR | 0.0% |
| 2008 | - INR | -100.0% |
| 2007 | 23.17 Billion INR | 47.66% |
| 2006 | 20.04 Billion INR | -12.75% |
| 2005 | 17.12 Billion INR | -44.63% |
| 2004 | 30.92 Billion INR | -17.06% |
| 2003 | 37.28 Billion INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 39.96 Billion INR | 0.94% |
| 2024 Q1 | 37.44 Billion INR | 2.84% |
| 2023 Q3 | 38.79 Billion INR | -2.49% |
| 2023 Q4 | 35.35 Billion INR | -8.87% |
| 2023 Q1 | 38.47 Billion INR | 3.05% |
| 2023 Q2 | 39.78 Billion INR | 3.41% |
| 2023 FY | - INR | -0.08% |
| 2022 Q2 | 35.88 Billion INR | 1.5% |
| 2022 Q1 | 35.35 Billion INR | 6.44% |
| 2022 Q4 | 37.33 Billion INR | -1.87% |
| 2022 FY | - INR | 12.27% |
| 2022 Q3 | 38.04 Billion INR | 6.02% |
| 2021 FY | - INR | 8.63% |
| 2021 Q4 | 33.21 Billion INR | -4.27% |
| 2021 Q3 | 34.69 Billion INR | 5.79% |
| 2021 Q2 | 32.79 Billion INR | 9.78% |
| 2021 Q1 | 29.87 Billion INR | -9.18% |
| 2020 Q2 | 30.18 Billion INR | 5.93% |
| 2020 Q3 | 30.17 Billion INR | -0.03% |
| 2020 Q1 | 28.49 Billion INR | 28.04% |
| 2020 FY | - INR | 16.22% |
| 2020 Q4 | 32.89 Billion INR | 9.02% |
| 2019 Q2 | 26.26 Billion INR | -8.47% |
| 2019 Q4 | 22.25 Billion INR | -15.53% |
| 2019 Q3 | 26.34 Billion INR | 0.3% |
| 2019 FY | - INR | 11.79% |
| 2019 Q1 | 28.69 Billion INR | 22.66% |
| 2018 Q3 | 21.66 Billion INR | -6.11% |
| 2018 FY | - INR | 19.34% |
| 2018 Q4 | 23.39 Billion INR | 7.99% |
| 2018 Q2 | 23.07 Billion INR | -5.84% |
| 2018 Q1 | 24.5 Billion INR | 0.0% |
| 2017 FY | - INR | 17.34% |
| 2016 FY | - INR | 5.47% |
| 2015 FY | - INR | 10.05% |
| 2014 FY | - INR | 11.95% |
| 2013 FY | - INR | 11.66% |
| 2012 FY | - INR | 21.24% |
| 2011 FY | - INR | 26.74% |
| 2010 FY | - INR | 2.02% |
| 2009 FY | - INR | 0.0% |
| 2008 FY | - INR | -100.0% |
| 2007 FY | - INR | 47.66% |
| 2006 FY | - INR | -12.75% |
| 2005 FY | - INR | -44.63% |
| 2004 FY | - INR | -17.06% |
| 2003 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Ador Multiproducts Limited | -24.81 Million INR | 614953.616% |
| Ambica Agarbathies Aroma & Industries Limited | 98.85 Million INR | -154230.167% |
| Bajaj Consumer Care Limited | 1.99 Billion INR | -7529.202% |
| Colgate-Palmolive (India) Limited | 19.57 Billion INR | -679.229% |
| Cupid Limited | 501.01 Million INR | -30350.368% |
| Dabur India Limited | 28.81 Billion INR | -429.437% |
| Emami Limited | 9.9 Billion INR | -1440.326% |
| Gillette India Limited | 6.27 Billion INR | -2331.545% |
| Godrej Consumer Products Limited | 7.23 Billion INR | -2008.114% |
| Hipolin Limited | -7.05 Million INR | 2163151.184% |
| Honasa Consumer Limited | 1.86 Billion INR | -8067.548% |
| JHS Svendgaard Laboratories Limited | 33.77 Million INR | -451581.667% |
| Jyothy Labs Limited | 5.33 Billion INR | -2759.446% |
| Kaya Limited | -233.46 Million INR | 65447.383% |
| Marico Limited | 21.67 Billion INR | -604.015% |
| N.K Industries Limited | 19.9 Million INR | -766456.125% |
| PAOS INDUSTRIES LIMITED | 1000.00 INR | -15255999900.0% |
| Paramount Cosmetics (India) Limited | 4.5 Million INR | -3390122.222% |
| Pee Cee Cosma Sope Limited | 159.57 Million INR | -95502.151% |
| Procter & Gamble Hygiene and Health Care Limited | 9.83 Billion INR | -1451.573% |